[1]
HENRIQUES PALMA, G. B.; KAUR, M. Cholesterol Depletion Modulates Drug Resistance Pathways to Sensitize Resistant Breast Cancer Cells to Tamoxifen. Anticancer Research, 2022, 42(1), 565-579.
[2]
Monchusi, B.; Kaur, M. miRNAs as Modulators of Cholesterol in Breast Cancer Stem Cells: An Approach to Overcome Drug Resistance in Cancer. Current Drug Targets, 2022, 23(6), 656-677.
[3]
Abdulla, N.; Vincent, C.T.; Kaur, M. Mechanistic Insights Delineating the Role of Cholesterol in Epithelial Mesenchymal Transition and Drug Resistance in Cancer. Front. Cell Dev. Biol., 2021, 9.
[4]
Khan, F.; Radovanovic, A.; Gojobori, T.; Kaur, M. IBDDB: a manually curated and text-mining-enhanced database of genes involved in inflammatory bowel disease. Database 2021, 2021.
[5]
Monchusi, B.; Kaur, M. microRNAs targeting cellular cholesterol: implications for combating anticancer drug resistance. Genes Cancer, 2020, 11(1-2), 20-42.
[6]
Esau, L.; Sagar, S.; Bangarusamy, D.; Kaur, M. Identification of CETP as a molecular target for estrogen positive breast cancer cell death by cholesterol depleting agents. Genes Cancer, 2016, 7(9-10), 309-322.
Article Metrics
3